1. Home
  2. EAF vs EMBC Comparison

EAF vs EMBC Comparison

Compare EAF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrafTech International Ltd.

EAF

GrafTech International Ltd.

HOLD

Current Price

$6.83

Market Cap

198.6M

Sector

Energy

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$5.23

Market Cap

199.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EAF
EMBC
Founded
1886
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.6M
199.9M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
EAF
EMBC
Price
$6.83
$5.23
Analyst Decision
Hold
Buy
Analyst Count
5
2
Target Price
$11.75
$18.50
AVG Volume (30 Days)
275.8K
1.6M
Earning Date
05-01-2026
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
1.03
Revenue
$504,134,000.00
N/A
Revenue This Year
$4.25
$1.17
Revenue Next Year
$12.49
N/A
P/E Ratio
N/A
$5.31
Revenue Growth
N/A
N/A
52 Week Low
$4.92
$2.77
52 Week High
$20.32
$15.55

Technical Indicators

Market Signals
Indicator
EAF
EMBC
Relative Strength Index (RSI) 44.31 69.08
Support Level $6.16 $3.01
Resistance Level $8.21 $9.38
Average True Range (ATR) 0.43 0.37
MACD -0.11 0.09
Stochastic Oscillator 15.88 81.21

Price Performance

Historical Comparison
EAF
EMBC

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products used as raw material in the production of graphite electrodes.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: